OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium
Rhea-AI Summary
OPKO Health (NASDAQ:OPK) announced its participation in the upcoming 3rd Annual Piper Sandler Virtual Obesity Symposium on June 26, 2025. The company's management will engage in a fireside discussion moderated by Edward Tentoff, Managing Director and Senior Biotechnology Analyst at Piper Sandler. Interested investors can register for the virtual event through their Piper Sandler representatives.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, OPK declined 1.55%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be participating in a fireside discussion moderated by Edward Tentoff, Managing Director, Senior Biotechnology Analyst. Investors can register for the symposium by contacting their Piper Sandler representative.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com
FAQ
When is OPKO Health (OPK) participating in the Piper Sandler Obesity Symposium?
Who will moderate OPKO Health's fireside discussion at the Piper Sandler symposium?
How can investors attend OPKO Health's presentation at the Piper Sandler Obesity Symposium?
What type of presentation will OPKO Health deliver at the Piper Sandler event?
